Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

CAS No. :	867160-71-2
Formula :	C₂₆H₂₃N₅O
M.W :	421.49
SMILES Code :	O[C@@]1(C)C[C@@H](C2=NC(C3=CC=C4C=CC(C5=CC=CC=C5)=NC4=C3)=C6C(N)=NC=CN62)C1
Synonyms :	OSI-906
English Name :	Cis-3-(8-Amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutan-1-ol
MDL No. :	MFCD12912153
InChI Key :	PKCDDUHJAFVJJB-UHFFFAOYSA-N
Pubchem ID :	11640390

GHS Pictogram:
Signal Word:
Hazard Statements:
Precautionary Statements:
Class:
UN#:
Packing Group:

CAFs	5 μM		Linsitinib evidently inhibited fibroblast proliferation	J Clin Invest. 2024 Nov 15;134(22):e183366.
iKras cells	1 μM	24 h	Enhanced nab-PTX uptake and cytotoxicity	Nat Nanotechnol. 2021 Jul;16(7):830-839.
A549	2 μM	1 day	Linsitinib alone or in combination with Dasatinib suppressed the phosphorylation of IGF-1R, Src, and Akt	Mol Cancer. 2015 Jun 4;14:113.
H226B	1 μM	5 days	Linsitinib treatment increased the stability of IGF-1R and Src proteins, enhancing the reciprocal co-activation of IGF-1R and Src	Mol Cancer. 2015 Jun 4;14:113.
liv7k oral cancer cell line	10 µM	72 h	To test the drug response of Linsitinib in liv7k oral cancer cells, the results showed cell viability under hypoxic and normoxic conditions.	Nat Commun. 2018 Jun 29;9(1):2546.
CAFs	5 μM		Linsitinib significantly reduced the CAF-mediated inhibition of T cell migration	J Clin Invest. 2024 Nov 15;134(22):e183366.
OMM1.3 cells	1 μM	24 h	To study the effect of Linsitinib on UM cell proliferation and cell cycle. It was found that Linsitinib alone had a less significant inhibitory effect on UM cell proliferation.	Mol Cancer Ther. 2023 Jan 3;22(1):63-74.
UM001 cells	1 μM	24 h	To study the effect of Linsitinib on UM cell proliferation and cell cycle. It was found that Linsitinib alone had a less significant inhibitory effect on UM cell proliferation.	Mol Cancer Ther. 2023 Jan 3;22(1):63-74.
92.1 cells	1 μM	24 h	To study the effect of Linsitinib on UM cell proliferation and cell cycle. It was found that Linsitinib alone had a less significant inhibitory effect on UM cell proliferation.	Mol Cancer Ther. 2023 Jan 3;22(1):63-74.
HCT-15	0.14 μM	96 h	Evaluate the effect of Linsitinib on HCT-15 cells, results show that Linsitinib exhibits resistance in HCT-15 cells.	Nat Commun. 2024 May 9;15(1):3909.
HT115	0.14 μM	96 h	Evaluate the effect of Linsitinib on HT115 cells, results show that Linsitinib exhibits resistance in HT115 cells.	Nat Commun. 2024 May 9;15(1):3909.
LS1034	0.14 μM	96 h	Evaluate the effect of Linsitinib on LS1034 cells, results show that Linsitinib exhibits sensitivity in LS1034 cells.	Nat Commun. 2024 May 9;15(1):3909.
NCI-H508	0.14 μM	96 h	Evaluate the effect of Linsitinib on NCI-H508 cells, results show that Linsitinib exhibits sensitivity in NCI-H508 cells.	Nat Commun. 2024 May 9;15(1):3909.
SNU-61	0.14 μM	96 h	Evaluate the effect of Linsitinib on SNU-61 cells, results show that Linsitinib exhibits resistance in SNU-61 cells.	Nat Commun. 2024 May 9;15(1):3909.
HCC4006	1 μM	72 h	Evaluate the effect of Linsitinib combined with Osimertinib on HCC4006 cells, results showed that the combination enhanced the effect of Osimertinib.	Nat Commun. 2020 Sep 14;11(1):4607.
HCC827	1 μM	72 h	Evaluate the effect of Linsitinib combined with Osimertinib on HCC827 cells, results showed that the combination enhanced the effect of Osimertinib.	Nat Commun. 2020 Sep 14;11(1):4607.
H3255	1 μM	72 h	Evaluate the effect of Linsitinib combined with Osimertinib on H3255 cells, results showed that the combination enhanced the effect of Osimertinib.	Nat Commun. 2020 Sep 14;11(1):4607.

Nude mice	NSCLC xenograft model	Oral	25 or 50 mg/kg	6 times per week for 3 weeks	Combined treatment with Linsitinib and Dasatinib significantly suppressed tumor growth and increased the levels of active caspase-3 in tumor tissues, while decreasing the expression of PCNA, pIGF-1R, and pSrc	Mol Cancer. 2015 Jun 4;14:113.
Mice	EO771 and MC38 tumor models	Intraperitoneal injection	10 mg/kg		Linsitinib significantly enhanced the therapeutic efficacy of immune checkpoint blockade, reduced tumor growth, and prolonged survival	J Clin Invest. 2024 Nov 15;134(22):e183366.
NSG mice	Metastatic UM mouse model	Oral gavage	25-40 mg/kg	Daily for two weeks	To test the inhibitory effect of Linsitinib in combination with YM-254890 on the growth of metastatic uveal melanoma tumors, results showed that the combination treatment significantly inhibited tumor growth.	Mol Cancer Ther. 2023 Jan 3;22(1):63-74.
Mice	HCC4006 cell line-derived xenograft model	Oral	50 mg/kg	Once daily for 10 days	Evaluate the effect of Linsitinib combined with Osimertinib on HCC4006 xenograft model, results showed that the combination induced tumor shrinkage and prevented regrowth.	Nat Commun. 2020 Sep 14;11(1):4607.
Mice	Intracranial xenograft model	Oral	50 mg/kg	Daily until neurological signs appeared	Linsitinib prolonged tumor latency and reduced tumor volumes	Cancer Discov. 2021 Feb;11(2):480-499

{[proInfo.proName]}

CAS No.: 867160-71-2

{[proInfo.proName]}

CAS No.: 867160-71-2

Alternative Products

Product Details of Linsitinib

Safety of Linsitinib

Related Pathways of Linsitinib

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT02546544	Relapsed Ewing Sarcoma\|Refract... More >>ory Ewing Sarcoma Less <<	PHASE2	COMPLETED	2016-07-15	Universitè Lyon 1 Claude Berna... More >>rd, Lyon, France\|Pediatric Hematology and Oncology, University Hospital Münster, Münster, 48149, Germany\|Istituti Ortopedici Rizzoli, Bologna, 40136, Italy\|Department of Clinical Oncology, Leiden University Medical Center, Leiden, Postzone K1-P, P.O. Box 9600, Netherlands\|Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE, United Kingdom Less <<
NCT00514007	Advanced Solid Tumors	PHASE1	COMPLETED	2012-03-19	Vanderbilt Universtiy Medical ... More >>Center, Nashville, Tennessee, 37232-6307, United States\|The Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom Less <<
NCT00514306	Advanced Solid Tumors	PHASE1	COMPLETED	2010-09-20	MD Anderson Cancer Center, Hou... More >>ston, Texas, 77030, United States\|Drug Development Unit, Royal Marsden Hospital, Sutton, Surrey, SM2 5PT, United Kingdom Less <<

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed